Cowen Inc’s Ultragenyx Pharmaceutical RARE Stock Holding History

Cowen Inc’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$2.16M	Buy	34,000 +4,000	+13%	+$255K	0.16%	104
2019 Q1	$2.08M	Hold	30,000	–	–	0.22%	75
2018 Q4	$1.3M	Buy	30,000 +10,000	+50%	+$547K	0.14%	118
2018 Q3	$1.53M	Hold	20,000	–	–	0.14%	118
2018 Q2	$1.54K	Buy	+20,000	New	+$1.29M	0.07%	174
2017 Q4	–	Sell	-12,175	Closed	-$648K	–	340
2017 Q3	$648K	Buy	+12,175	New	+$721K	0.02%	151
2015 Q2	–	Sell	-4,050	Closed	-$251K	–	513
2015 Q1	$251K	Sell	4,050 -145,382	-97%	-$8.08M	0.02%	275
2014 Q4	$6.56M	Buy	149,432 +500	+0.3%	+$22.9K	0.52%	28
2014 Q3	$8.43M	Buy	148,932 +8,595	+6%	+$432K	0.87%	20
2014 Q2	$6.3M	Buy	+140,337	New	+$5.78M	0.71%	24

Other funds holding RARE

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Cowen Inc's RARE Position: Q2 2019 in Review

Cowen Inc increased its Ultragenyx Pharmaceutical (RARE) stake by 13% in Q2 2019, buying an estimated $255K and bringing the position to 34,000 shares worth $2.16M. The position accounts for 0.16% of the portfolio, ranked #104.

Cowen Inc first reported a position in RARE in Q2 2014 and has held it in 10 quarters since. The position peaked at $8.43M in Q3 2014. 170 funds tracked by Wall St. Rank hold RARE as of Q2 2019.

Cowen Inc held 34,000 shares of Ultragenyx Pharmaceutical worth $2.16M as of Q2 2019.
Cowen Inc bought 4,000 Ultragenyx Pharmaceutical shares in Q2 2019, an estimated $255K.
Ultragenyx Pharmaceutical made up 0.16% of Cowen Inc's portfolio in Q2 2019, its #104 holding.
Cowen Inc first reported a position in Ultragenyx Pharmaceutical in Q2 2014 and has held it in 10 quarters since.
Cowen Inc's Ultragenyx Pharmaceutical position peaked at $8.43M in Q3 2014.
170 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.